Rosen, Joseph G.
Thompson, Erin
Tardif, Jessica
Collins, Alexandra B.
Marshall, Brandon D. L.
Park, Ju Nyeong
Funding for this research was provided by:
National Institute of Mental Health (F31MH126796)
Center of Biomedical Research Excellence on Opioids and Overdose, United States (P20GM125507)
Center of Biomedical Research Excellence on Opioids and Overdose, United States (P20GM125507)
Center of Biomedical Research Excellence on Opioids and Overdose, United States (P20GM125507)
Providence/Boston Center for AIDS Research, United States (P30AI042853)
Article History
Received: 7 November 2023
Accepted: 3 February 2024
First Online: 15 February 2024
Declarations
:
: The study was approved by the Lifespan Institutional Review Board (Providence, RI, USA). All individuals provided verbal informed consent prior to study enrollment.
: Not applicable.
: JNP serves as a technical consultant on a grant funded by the U.S. Food and Drug Administration (U01FD00745501). The remaining authors have no competing interests to declare.